Escitalopram and Duloxetine in Major Depressive Disorder: A Pharmacoeconomic Comparison Using UK Cost Data

By Wade Alan G.  

PharmacoEconomics, Vol. 26, Iss. 11, 2008-01 ,pp. : 969-981

Adis International

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H.   Scott Lesley J.  

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite

Escitalopram for the treatment of major depressive disorder in youth

By Ahn Joon-Ho   Patkar Ashwin A  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2235-2244

Informa Healthcare

Access to resources Recommend Favorite

Open-Label Treatment with Desvenlafaxine in Postmenopausal Women with Major Depressive Disorder Not Responding to Acute Treatment with Desvenlafaxine or Escitalopram

By Soares Claudio N.  

CNS Drugs, Vol. 25, Iss. 3, 2011-03 ,pp. : 227-238

Adis International

Access to resources Recommend Favorite

Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol

By Andrezina Raisa   Josiassen Richard   Marcus Ronald   Oren Dan   Manos George   Stock Elyse   Carson William   Iwamoto Taro  

Psychopharmacology, Vol. 188, Iss. 3, 2006-10 ,pp. : 281-292

Springer Publishing Company

Access to resources Recommend Favorite